Bumetanide and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Naproxen, and have Lower respiratory tract infection.

The phase IV clinical study analyzes which people have Icterus when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,529 Bumetanide users. Check the latest studies of Bumetanide.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 2,208 drugs and 2,985 conditions by eHealthMe. Check the latest studies of Icterus.

On Oct, 20, 2025

20,353 people reported to have side effects when taking Bumetanide.
Among them, 47 people (0.23%) have Icterus.

Among these 47 people:

How long have people been on Bumetanide when they have Icterus? *

What is the gender of people who have Icterus when taking Bumetanide? *

female: 57.78 %
male: 42.22 %

What is the age of people who have Icterus when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

Naproxen: 8 people, 17.02%
Levothyroxine Sodium: 6 people, 12.77%
Omeprazole: 6 people, 12.77%
Enalapril Maleate: 6 people, 12.77%
Amoxicillin And Clavulanate Potassium: 6 people, 12.77%
Spironolactone: 6 people, 12.77%
Acetaminophen: 5 people, 10.64%
Senna: 5 people, 10.64%
Folic Acid: 5 people, 10.64%
Amoxicillin: 5 people, 10.64%

What are other side effects people have besides Icterus? *

Liver Function Test Abnormal: 14 people, 29.79%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 10 people, 21.28%
Encephalitis (inflammation of the brain): 7 people, 14.89%
Hepatitis (inflammation of the liver): 7 people, 14.89%
Blood Bilirubin Increased: 6 people, 12.77%
Blood Alkaline Phosphatase Increased: 6 people, 12.77%
Aspartate Aminotransferase Increased: 5 people, 10.64%
Liver Disorder (liver diseases): 5 people, 10.64%
Nausea (feeling of having an urge to vomit): 5 people, 10.64%
Gamma-Glutamyltransferase Increased: 5 people, 10.64%

What are the existing conditions these people have? *

Lower Respiratory Tract Infection: 6 people, 12.77%
Oedema (fluid collection in tissue): 5 people, 10.64%
Urinary Tract Infection: 5 people, 10.64%
Hyperthyroidism (over activity of the thyroid gland): 3 people, 6.38%
Joint Pain: 3 people, 6.38%
Constipation: 3 people, 6.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 4.26%
Cellulitis (infection under the skin): 2 people, 4.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.26%
High Blood Cholesterol: 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,529 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (2,208 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (2,985 conditions)

Drugs similar to Bumetanide and Icterus :

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.